Cutaneous Lupus Erythematosus - 26 Studies Found

Completed : Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
: Cutaneous Lupus Erythematosus (CLE)
: 2008-03-04
: Drug: lenalidomide (Revlimid®) The drug will be administered in oral form. The dosage of lenalidomi
Completed : Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion
: Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
: 2012-03-08
:
  • Drug: hydroxychloroquine (Z0188)

Recruiting : Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
:
  • Systemic Lupus Erythematosus (SLE)
  • Active Cutaneous Lupus Erythematosu
    : 2016-06-06
    :
    • Drug: BIIB059 Anti-BDCA2
Terminated : Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
: Lupus Erythematosus, Cutaneous
: 2011-08-01
: Drug: Alitretinoin 1 capsule Alitretinoin 30 mg per day; optional reduction to 10 mg per day in case una
Recruiting : Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Patients
: Lupus Erythematosus, Cutaneous
: 2016-08-30
:
  • Drug: GSK2646264 1% A cream fo
Completed : Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
: Lupus Erythematosus, Cutaneous
: 2011-04-29
: Drug: Fumaric acid esters Starting from 1 tablet Fumaderm® initial per day, with titration up to 6
Completed : Cutaneous Lupus Erythematosus and Elidel
:
  • Lupus Erythematosus, Cutaneous
  • Lupus Erythematosus, Discoid : 2005-09-19
    : Drug: Elidel (pimecrolimus)
Enrolling by invitation : European Society of Cutaneous Lupus Erythematosus (EUSCLE)
:
  • Lupus Erythematosus, Cutaneous
  • Lupus Erythematosus, Systemic : 2007-01-08
    : Procedure: laboratory analysis blood withdrawal for laboratory analysis
Completed : A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
:
  • Lupus Erythematosus, Cutaneous
  • Lupus Erythematosus, Systemic : 2012-07-06
    :
    • Drug: 1 mg/kg CNTO 136 Type=ex
Terminated : Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus
: Cutaneous Lupus Erythematosus
: 2011-12-21
: Dietary Supplement: vitamin D The investigators will carry out a two-armed prospective pilot study of th
<<< Previous | Next >>>